Restricted accessResearch articleFirst published online 2015-11
Dual-Energy Multidetector Computed Tomography with Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced Phase?
PonzianiF.R.ZoccoM.A.CampanaleC.Portal vein thrombosis: insight into physiopathology, diagnosis, and treatmentWorld J Gastroenterol2010; 16:143–155.
2.
OgrenM.BergqvistD.BjorckM.AcostaS.ErikssonH.SternbyN.H.Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsiesWorld J Gastroenterol2006; 12:2115–2119.
3.
PiscagliaF.GianstefaniA.RavaioliM.Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantationLiver Transpl2010; 16:658–667.
4.
RazaS.A.JangH.J.KimT.K.Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasoundAbdom Imaging2014; 39:153–161.
5.
TarantinoL.FrancicaG.SordelliI.Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsyAbdom Imaging2006; 31:537–544.
6.
RossiS.GhiottoniG.RavettaV.Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinomaEur Radiol2008; 18:1749–1756.
7.
CatalanoO.A.ChoyG.ZhuA.HahnP.F.SahaniD.V.Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imagingRadiology2010; 254:154–162.
8.
SandrasegaranK.TahirB.NutakkiK.Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patientsAJR Am J Roentgenol2013; 201:1211–1219.
9.
ParveyH.R.RavalB.SandlerC.M.Portal vein thrombosis: imaging findingsAJR Am J Roentgenol1994; 162:77–81.
10.
MarnC.S.FrancisI.R.CT of portal venous occlusionAJR Am J Roentgenol1992; 159:717–726.
11.
TublinM.E.DoddG.D.IIIBaronR.L.Benign and malignant portal vein thrombosis: differentiation by CT characteristicsAJR Am J Roentgenol1997; 168:719–723.
12.
ChandaranaH.MegibowA.J.CohenB.A.Iodine quantification with dual-energy CT: phantom study and preliminary experience with renal massesAJR Am J Roentgenol2011; 196:693–700.
13.
AscentiG.MiletoA.KraussB.Distinguishing enhancing from nonenhancing renal masses with dual-source dual-energy CT: iodine quantification versus standard enhancement measurementsEur Radiol2013; 23:2288–2295.
14.
QianL.J.ZhuJ.ZhuangZ.G.Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot studyEur Radiol2012; 22:2178–2185.
15.
GraserA.JohnsonT.R.HechtE.M.Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images?Radiology2009; 252:433–440.
16.
BrinkJ.A.Use of high concentration contrast media (HCCM): principles and rationale-body CTEur J Radiol2003; 45:S53–S58.
17.
AscentiG.MazziottiS.LambertoS.Dual-energy CT for detection of endoleaks after endovascular abdominal aneurysm repair: usefulness of colored iodine overlayAJR Am J Roentgenol2011; 196:1408–1414.
18.
AscentiG.MazziottiS.MiletoA.Dual-source dual-energy CT evaluation of complex cystic renal massesAJR Am J Roentgenol2012; 199:1026–1034.
19.
MenzelH.SchibillaH.TeunenD.European Guidelines on Quality Criteria for Computed Tomography. Publication no. EUR 16262 EN2000European CommissionLuxembourg
20.
MiletoA.MazziottiS.GaetaM.Pancreatic dual-source dual-energy CT: is it time to discard unenhanced imaging?Clin Radiol2012; 67:334–339.
21.
ShahZ.K.McKernanM.G.HahnP.F.SahaniD.V.Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesionsAJR Am J Roentgenol2007; 188:1320–1323.
22.
AltenberndJ.HeusnerT.A.RingelsteinA.LaddS.C.ForstingM.AntochG.Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivityEur Radiol2011; 21:738–743.
23.
MarinD.NelsonR.C.SameiE.Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection–initial clinical experienceRadiology2009; 251:771–779.
24.
AscentiG.KraussB.MazziottiS.Dual-energy computed tomography (DECT) in renal masses: nonlinear versus linear blendingAcad Radiol2012; 19:1186–1193.
25.
De CeccoC.N.BuffaV.FedeliS.Dual Energy CT (DECT) of the liver: conventional versus virtual nonenhanced imagesEur Radiol2010; 20:2870–2875.
26.
MiletoA.MarinD.NelsonR.C.AscentiG.BollD.T.Dual energy MDCT assessment of renal lesions: an overviewEur Radiol2014; 24:353–362.
27.
ScheffelH.StolzmannP.FrauenfelderT.Dual-energy contrast-enhanced computed tomography for the detection of urinary stone diseaseInvest Radiol2007; 42:823–829.
